Your email has been successfully added to our mailing list.

×
0.0452674897119341 0.0452674897119341 0.0452674897119341 0.0452674897119341 0.0452674897119341 0.0452674897119341 0.0452674897119341 0.0452674897119341
Stock impact report

Iterum Therapeutics Announces Completion of Enrollment in Phase 3 Clinical Trial of Oral Sulopenem in Uncomplicated Urinary Tract Infection

Iterum Therapeutics plc - Ordinary Share (ITRM) 
Last iterum therapeutics plc - ordinary share earnings: 11/12 04:30 pm Check Earnings Report
Company Research Source: GlobeNewswire
DUBLIN, Ireland and CHICAGO, Dec. 26, 2019 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM), a clinical-stage pharmaceutical company focused on developing next generation oral and IV antibiotics to treat infections caused by multi-drug resistant pathogens in both community and hospital settings, today announced the completion of patient enrollment in its Sulopenem for Resistant Enterobacteriaceae (SURE) 1 clinical trial in uncomplicated urinary tract infections (uUTI). “We are pleased to announce the completion of enrollment in our final phase 3 trial for uncomplicated urinary tract infections (uUTI) with over 1,670 patients treated. Topline results from this trial are expected in the first quarter of 2020,” said Corey Fishman, Chief Executive Officer of Iterum Therapeutics. “It has been over 20 years since a new, oral treatment has been developed for urinary tract infections and the existing orals are no longer effective.  If approved, oral sulopenem will provide an opti Show less Read more
Impact Snapshot
Event Time:
ITRM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for ITRM alerts
Opt-in for
ITRM alerts

from News Quantified
Opt-in for
ITRM alerts

from News Quantified